Phase
Condition
Chest Pain
Arrhythmia
Atrial Flutter
Treatment
Pulse Field Ablation (PFA)
Radiofrequency ablation
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
1.Patients aged ≥18 years. 2.Diagnosed with persistent symptomatic refractory mitral valve commissural-dependent atrial flutter. Refractory mitral valve commissural-dependent atrial tachycardia is defined as:
Failure of drug therapy: At least one Class I or III antiarrhythmic drug (e.g.,propafenone, amiodarone) fails to effectively control or prevent episodes.
Failure of catheter ablation: At least one previous attempt at radiofrequencycatheter ablation (RFCA) targeting the mitral valve commissure has been unsuccessful (either due to recurrence post-procedure or failure to achieve bidirectional blockat the commissure).
3.Intolerant to at least one antiarrhythmic drug (AAD). 4.The patient must be capable of and willing to provide written informed consent to participate in this study.
Exclusion
Exclusion Criteria:
Pregnant or breastfeeding women.
Presence of left atrial thrombus on preoperative imaging.
Life expectancy less than 1 year.
Coagulation disorders or contraindications to anticoagulant therapy.
Study Design
Study Description
Connect with a study center
Shanghai Chest Hospital
Shanghai,
ChinaSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.